ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Outpatient Talc Administration by Indwelling Pleural Catheter for Malignant Effusion

Thursday, April 5, 2018

Submitted by

Claire Vernon

Source

Source Name: New England Journal of Medicine

Source URL: http://www.nejm.org/doi/full/10.1056/NEJMoa1716883

Author(s)

Rahul Bhatnagar, Emma K. Keenan, Anna J. Morley, Brennan C. Kahan, Andrew E. Stanton, Mohammed Haris, Richard N. Harrison, Rehan A. Mustafa, Lesley J. Bishop, Liju Ahmed, Alex West, Jayne Holme, Matthew Evison, Mohammed Munavvar, Pasupathy Sivasothy, Jurgen Herre, David Cooper, Mark Roberts, Anur Guhan, Clare Hooper, James Walters, Tarek S. Saba, Biswajit Chakrabarti, Samal Gunatilake, Ioannis Psallidas, Steven P. Walker, Anna C. Bibby, Sarah Smith, Louise J. Stadon, Natalie J. Zahan-Evans, Y.C. Gary Lee, John E. Harvey, Najib M. Rahman, Robert F. Miller, Nick A. Maskell

Bhatnagar and colleagues randomized patients with malignant pleural effusion in order to test an outpatient approach to pleurodesis. All patients had indwelling pleural catheters placed for drainage, and they received a daily administration of either talc slurry or placebo through the catheter on an outpatient basis. Pleurodesis was evaluated after 35 days, with 30 of 69 patients (43%) in the talc group and 16 of 70 patients (23%) in the placebo group demonstrating successful pleurodesis.